Principal Pathologist

Regeneron Pharmaceuticals; Tarrytown (GA); On-site; USD 151,000 - 246,000; Full time

Job summary

Regeneron Pharmaceuticals is seeking a Principal Pathologist to advance innovative medicines from discovery through development. You will provide critical pathology expertise across the drug development continuum and lead pathology reviews for toxicology studies, partnering with researchers on diverse modalities including gene therapies and large molecules.

The role is based on-site in Tarrytown, NY, four days per week, with collaboration across a multidisciplinary team in Regeneron’s Drug

Qualifications

• DVM or PhD in Pathology is required.
• Board certification in veterinary anatomic pathology (DACVP or DECVP) is required.
• Experience at a contract research organization is preferred.

Responsibilities

• Provide critical pathology expertise across the drug development continuum.
• Serve as the study pathologist for in-house discovery studies and produce high-quality pathology reports.
• Provide pathology peer review for Regeneron toxicology studies conducted at contract research organizations.
• Leverage digital image analysis to strengthen study interpretation where appropriate.
• Contribute to the development of an in-house digital pathology program.
• Present scientific contributions in internal and external forums supporting regulatory and discovery programs.
• Contribute to scientific publications and abstracts.
• Stay connected with the toxicologic pathology community through seminars and conferences.

Skills

Pathology

Toxicology

Education

DVM or PhD in Pathology

Board certification in veterinary anatomic pathology (DACVP or DECVP)

Job description

Build Our Future Together:

The Pathology group within Regeneron’s Drug Safety and Pharmacometrics organization is looking for a Principal Pathologist who is excited to help advance innovative medicines from discovery through development. In this highly collaborative role, you will provide critical pathology expertise across the drug development continuum, including pathology peer review of Regeneron toxicology studies and close partnership with research scientists to support the discovery, characterization, and preclinical development of diverse therapeutic modalities, including large-molecule therapeutics, gene therapies, and oligonucleotide-based drugs targeting a broad range of diseases.

When & Where:

This position will be based on-site in our Tarrytown, NY offices four days per week.

Discover Your Role:

• Apply your expertise in toxicologic pathology to help shape research programs that support the discovery and development of transformative medicines.
• Serve as the study pathologist for in-house discovery studies and produce high-quality pathology reports that inform scientific decision-making and support regulatory submissions.
• Provide digital or glass-slide pathology peer review for Regeneron toxicology studies conducted at contract research organizations.
• Leverage digital image analysis, when appropriate, to strengthen study interpretation and scientific insight.
• Contribute to the continued development of a forward-looking, in-house digital pathology program.
• Present your scientific contributions through internal and external forums that support regulatory and discovery programs.
• Contribute to scientific publications, including manuscripts, abstracts, posters, and oral presentations.
• Stay connected with the toxicologic pathology community through seminars, workshops, and conferences.

This Role Requires:

• DVM or PhD in Pathology
• Board certification in veterinary anatomic pathology (DACVP or DECVP).
• Experience at a contract research organization is preferred.

We are committed to building a workplace with an inclusive culture. Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Traveler community, familial status, genetic information, military or veteran status, or any other characteristic protected under applicable law. Where required, we will provide reasonable accommodation to applicants with known disabilities or chronic illnesses during the recruitment process, unless such accommodation would impose undue hardship.

Where necessary, we disclose salary ranges for roles in all countries in which we operate. The final offer will be determined within the relevant range based on the country of employment, specific role level, and your skills and experience. In some countries, collective bargaining agreements (CBAs) may apply and influence certain elements of pay or benefits. Regeneron offers a competitive and comprehensive total rewards package which may include, depending on country and role: annual bonuses or other incentive plans, equity awards, pension or retirement benefits, 401(k) company match, health and wellness programs, fitness centers, insurance benefits (e.g. medical, dental, vision, life and disability), paid time off, and family support benefits. For additional information about Regeneron benefits in the U.S., please visit https://careers.regeneron.com/en/working-at-regeneron/total-rewards/. For other locations, additional information will be provided during the recruitment process.

Please be advised that at Regeneron, we believe we do our best work when we are together. For that reason, many roles are required to be performed on‑site.

As part of the recruitment process, certain background checks may be conducted in accordance with the laws of the country where the position is based. The purpose of such checks is to verify certain information prior to the commencement of employment such as identity, right to work and educational qualifications.

For jobs in Canada: this posting is for an existing position.

Salary Range (annually)

$150,500.00 - $245,500.00